Literature DB >> 22436428

Monoamine oxidase A gene DNA hypomethylation - a risk factor for panic disorder?

Katharina Domschke1, Nicola Tidow, Henriette Kuithan, Kathrin Schwarte, Benedikt Klauke, Oliver Ambrée, Andreas Reif, Hartmut Schmidt, Volker Arolt, Anette Kersting, Peter Zwanzger, Jürgen Deckert.   

Abstract

The monoamine oxidase A (MAOA) gene has been suggested as a prime candidate in the pathogenesis of panic disorder. In the present study, DNA methylation patterns in the MAOA regulatory and exon 1/intron 1 region were investigated for association with panic disorder with particular attention to possible effects of gender and environmental factors. Sixty-five patients with panic disorder (44 females, 21 males) and 65 healthy controls were analysed for DNA methylation status at 42 MAOA CpG sites via direct sequencing of sodium bisulfate treated DNA extracted from blood cells. The occurrence of recent positive and negative life events was ascertained. Male subjects showed no or only very minor methylation with some evidence for relative hypomethylation at one CpG site in intron 1 in patients compared to controls. Female patients exhibited significantly lower methylation than healthy controls at 10 MAOA CpG sites in the promoter as well as in exon/intron 1, with significance surviving correction for multiple testing at four CpG sites (p≤0.001). Furthermore, in female subjects the occurrence of negative life events was associated with relatively decreased methylation, while positive life events were associated with increased methylation. The present pilot data suggest a potential role of MAOA gene hypomethylation in the pathogenesis of panic disorder particularly in female patients, possibly mediating a detrimental influence of negative life events. Future studies are warranted to replicate the present finding in independent samples, preferably in a longitudinal design.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22436428     DOI: 10.1017/S146114571200020X

Source DB:  PubMed          Journal:  Int J Neuropsychopharmacol        ISSN: 1461-1457            Impact factor:   5.176


  44 in total

Review 1.  Revise the revised? New dimensions of the neuroanatomical hypothesis of panic disorder.

Authors:  Thomas Dresler; Anne Guhn; Sara V Tupak; Ann-Christine Ehlis; Martin J Herrmann; Andreas J Fallgatter; Jürgen Deckert; Katharina Domschke
Journal:  J Neural Transm (Vienna)       Date:  2012-06-13       Impact factor: 3.575

Review 2.  Candidate genes in panic disorder: meta-analyses of 23 common variants in major anxiogenic pathways.

Authors:  A S Howe; H N Buttenschøn; A Bani-Fatemi; E Maron; T Otowa; A Erhardt; E B Binder; N O Gregersen; O Mors; D P Woldbye; K Domschke; A Reif; J Shlik; S Kõks; Y Kawamura; A Miyashita; R Kuwano; K Tokunaga; H Tanii; J W Smoller; T Sasaki; D Koszycki; V De Luca
Journal:  Mol Psychiatry       Date:  2015-09-22       Impact factor: 15.992

3.  Tobacco and cannabis use in college students are predicted by sex-dimorphic interactions between MAOA genotype and child abuse.

Authors:  Paula J Fite; Shaquanna Brown; Waheeda Hossain; Ann Manzardo; Merlin G Butler; Marco Bortolato
Journal:  CNS Neurosci Ther       Date:  2018-06-27       Impact factor: 5.243

4.  Optimizing exposure-based CBT for anxiety disorders via enhanced extinction: Design and methods of a multicentre randomized clinical trial.

Authors:  Ingmar Heinig; Andre Pittig; Jan Richter; Katrin Hummel; Isabel Alt; Kristina Dickhöver; Jennifer Gamer; Maike Hollandt; Katja Koelkebeck; Anne Maenz; Sophia Tennie; Christina Totzeck; Yunbo Yang; Volker Arolt; Jürgen Deckert; Katharina Domschke; Thomas Fydrich; Alfons Hamm; Jürgen Hoyer; Tilo Kircher; Ulrike Lueken; Jürgen Margraf; Peter Neudeck; Paul Pauli; Winfried Rief; Silvia Schneider; Benjamin Straube; Andreas Ströhle; Hans-Ulrich Wittchen
Journal:  Int J Methods Psychiatr Res       Date:  2017-03-21       Impact factor: 4.035

Review 5.  Sex differences modulating serotonergic polymorphisms implicated in the mechanistic pathways of risk for depression and related disorders.

Authors:  LeeAnn M Perry; Andrea N Goldstein-Piekarski; Leanne M Williams
Journal:  J Neurosci Res       Date:  2017-01-02       Impact factor: 4.164

Review 6.  [Patho- and therapyepigenetics of mental disorders].

Authors:  Christiane Ziegler; Miriam A Schiele; Katharina Domschke
Journal:  Nervenarzt       Date:  2018-11       Impact factor: 1.214

Review 7.  Epigenetic signature of MAOA and MAOB genes in mental disorders.

Authors:  Christiane Ziegler; Katharina Domschke
Journal:  J Neural Transm (Vienna)       Date:  2018-09-21       Impact factor: 3.575

8.  Oxytocin receptor gene methylation: converging multilevel evidence for a role in social anxiety.

Authors:  Christiane Ziegler; Udo Dannlowski; David Bräuer; Stephan Stevens; Inga Laeger; Hannah Wittmann; Harald Kugel; Christian Dobel; René Hurlemann; Andreas Reif; Klaus-Peter Lesch; Walter Heindel; Clemens Kirschbaum; Volker Arolt; Alexander L Gerlach; Jürgen Hoyer; Jürgen Deckert; Peter Zwanzger; Katharina Domschke
Journal:  Neuropsychopharmacology       Date:  2015-01-07       Impact factor: 7.853

9.  [Predictive factors of anxiety disorders].

Authors:  K Domschke
Journal:  Nervenarzt       Date:  2014-10       Impact factor: 1.214

10.  Pharmacoepigenetics of depression: no major influence of MAO-A DNA methylation on treatment response.

Authors:  Katharina Domschke; Nicola Tidow; Kathrin Schwarte; Christiane Ziegler; Klaus-Peter Lesch; Jürgen Deckert; Volker Arolt; Peter Zwanzger; Bernhard T Baune
Journal:  J Neural Transm (Vienna)       Date:  2014-05-10       Impact factor: 3.575

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.